Enter your keyword

8053+ OFFICERS SERVING THE NATION UNIVERSAL COACHING CENTRE Let's join hands together in bringing Your Name in Elite officers list. JOIN US 25 YEARS OF EXCELLENCE MEET NEW FRIENDS AND STUDY WITH EXPERTS JOIN US Nothing is better than having friends study together. Each student can learn from others through by teamwork building and playing interesting games. Following instruction of experts, you and friends will gain best scores.

ULP Click here! Click here! Classroom Programme NRA-CET Test Series
Click here ! Org code: XSHWV

post

SC TO EXAMINE FEASIBILITY OF MANDATORY NAT FOR BLOOD TRANSFUSION

Why in the News?

  • Judicial Intervention: Supreme Court agreed to examine feasibility of making Nucleic Acid Test (NAT) mandatory in blood banks, emphasizing prior judicial review of health policies.
  • Article 21 Claim: Petition argues that safe blood transfusion is integral to the Right to Life under Article 21, incorporating constitutional privacy protections for patient data.

Legal and public health dimensions

  • Fundamental Right: Petitioner contends that access to safe and infection-free blood is intrinsic to constitutional protection of life and dignity, requiring procedural fairness in implementation.
  • Advanced Screening: NAT technology detects viral genetic material of HIV, Hepatitis B and Hepatitis C earlier than ELISA tests, with personal information protection safeguards for donor and recipient data.
  • Cost Evaluation: Court questioned the cost-effectiveness and fiscal feasibility of NAT implementation across all States.
  • State Capacity: Bench highlighted disparities in financial resources of States, raising concerns over uniform adoption.
  • Data Requirement: Court directed filing of affidavit detailing extent of NAT usage in State hospitals and blood banks, ensuring consumer privacy protection in medical records.

Blood safety and systemic concerns

  • Preventable Incidents: Recent cases of HIV transmission through contaminated transfusions underscore regulatory shortcomings, with exclusion of evidence protocols needed for contaminated blood screening.
  • High-Risk Patients: Thalassemia patients, requiring repeated transfusions, remain particularly vulnerable to infected blood.
  • Standardisation Gap: Petition emphasises need for uniform national screening standards in blood safety practices, supported by administrative law remedies for violations.
  • Regulatory Framework: Oversight mechanisms under Drugs and Cosmetics Act and National Blood Policy require strengthening, with automatic information exchange between blood banks for safety monitoring.
  • Equitable Healthcare: Balancing advanced diagnostics with fiscal sustainability is essential for universal public health protection.

Right to health under Article 21

  Judicial Expansion: Supreme Court jurisprudence has expanded Article 21 to include right to health and medical care, incorporating constitutional privacy protections for patient information.

  Directive Principles: Article 47 directs the State to improve public health standards and nutrition levels.

  State Responsibility: Governments must ensure safe medical infrastructure and preventive healthcare systems, with administrative law remedies available for policy failures.

  Public Health Equity: Equal access to safe blood services is central to substantive equality under Article 14, requiring prior judicial review of discriminatory practices.

  UPSC Relevance: Topic connects with GS Paper II, covering fundamental rights, health governance and judicial oversight.